首页|Traceable Lactate-Fueled Self-Acting Photodynamic Therapy against Triple-Negative Breast Cancer
Traceable Lactate-Fueled Self-Acting Photodynamic Therapy against Triple-Negative Breast Cancer
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
The depth of light penetration and tumor hypoxia restrict the efficacy of photodynamic therapy(PDT)in triple-negative breast cancer(TNBC),while the overproduction of lactate(LA)facilitates the development,aggressiveness,and therapy resistance of TNBC.To address these issues,a self-acting PDT nanosystem(HL@hMnO2-LOx@HA)is fabricated by loading 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-alpha(HPPH),luminol,and LA oxidase(LOx)in a hyaluronic acid(HA)-coated hollow manganese dioxide(hMnO2)nanoparticle.LOx catalyzes the oxidation of LA into pyruvate and hydrogen peroxide(H2O2),thus depleting the overproduced intratumoral LA.In the acidic tumor microenvironment,H2O2 reacts with luminol and hMnO2 to yield blue luminescence as well as O2 and Mn2+,respectively.Mn2+could further enhance this chemiluminescence.HPPH is then excited by the chemiluminescence through chemiluminescence resonance energy transfer for self-illuminated PDT.The generated O2 alleviates the hypoxia state of the TNBC tumor to produce sufficient 1O2 for self-oxygenation PDT.The Mn2+performs T1 magnetic resonance imaging to trace the self-acting PDT process.This work provides a biocompatible strategy to conquer the limits of light penetration and tumor hypoxia on PDT against TNBC as well as LA overproduction.
Marshall Laboratory of Biomedical Engineering,International Cancer Center,Shenzhen Key Laboratory of Tumor Visualization Molecular Medicine,Laboratory of Evolutionary Theranostics(LET),School of Biomedical Engineering,Shenzhen University Medical School,Shenzhen University,Shenzhen 518055,China
NETL
NSTL
万方数据
